CASR and neonatal severe primary hyperparathyroidism: Milder phenotypes are summarized as neonatal hyperparathyroidism (NHPT) and refer to infants with elevated serum PTH levels and resulting bone disease, but only modest hypercalcemia, usually based on heterozygous inactivating mutations of CaSR (15).